A5101420187- Pancreatic and Hepatic Oncology Research
- Viral-associated cancers and disorders
- Lung Cancer Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Head and Neck Cancer Studies
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Cancer-related molecular mechanisms research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Calcium signaling and nucleotide metabolism
- Genetic factors in colorectal cancer
- PARP inhibition in cancer therapy
- Neuroendocrine Tumor Research Advances
- Ovarian cancer diagnosis and treatment
- Venous Thromboembolism Diagnosis and Management
- Salivary Gland Tumors Diagnosis and Treatment
- Colorectal Cancer Screening and Detection
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Colorectal Cancer Surgical Treatments
- Colorectal and Anal Carcinomas
- Autophagy in Disease and Therapy
- Testicular diseases and treatments
Sun Yat-sen University
2020-2025
Sun Yat-sen University Cancer Center
2020-2025
University of Colorado Denver
2022
University of Colorado Cancer Center
2022
State Key Laboratory of Oncology in South China
2020
Jiangsu Cancer Hospital
2017-2018
Nanjing Medical University
2017
As a novel inflammatory-nutritional biomarker, the C-reactive protein-albumin-lymphocyte (CALLY) index has demonstrated significant prognostic value in various malignancies. However, research on its association with prognosis of ampullary carcinoma (AC) is rare. This study aims to investigate relationship between CALLY and patients AC. We retrospectively analyzed data from 201 AC at Sun Yat-sen University Cancer Center. Several clinicopathological factors biomarkers were included study....
Background: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare yet aggressive malignancy. This study aims to investigate deep learning model based on hematological indices, referred as haematological indices-based signature (HIBS), and propose multivariable predictive models for accurate prognosis prediction assessment of therapeutic response immunotherapy in PPLELC.
Microvascular invasion (MVI) plays an important role in tumor progression. The aim of this study is to establish and validate effective hematological nomogram for MVI prediction hepatocellular carcinoma (HCC).A retrospective was performed a primary cohort that includes 1306 patients clinicopathologically diagnosed with HCC, validation contained 563 continuous patients. Univariate logistic regression used assess the association between variables included both clinicopathologic factors...
A female prognostic advantage in younger individuals has been demonstrated various cancers. Several large-scale analyses based on different racial backgrounds have reported inconsistent results colorectal cancer. The aim of the present study was to evaluate value sex and age patients with cancer ethnic groups.We identified 71,812 eligible from Surveillance, Epidemiology End Results database. According at diagnosis, were categorized into premenopausal (≤45 yrs), menopausal (46-54...
<title>Abstract</title> <bold>Background: </bold>Radical resection is the only curative method for patients with pancreatic adenocarcinoma (PDAC). However, nearly 85% of PDAC suffer from local or distant recurrence within five years after resection. Furthermore, progression recurrent lesions accelerated death patients. influence clinicopathological factors on post-progression-free survival (PPFS), defined as period tumor to timing lesions, has rarely been discussed. The present study aimed...
<title>Abstract</title> Background Pancreatic adenocarcinoma (PDAC) is a lethal disease with five-year survival rate of less than 10%. The immunosuppressive tumor microenvironment (TME) was primarily responsible for the poor prognosis in PDAC. M2 Macrophages are crucial cell population pro-tumorigenic effects response to extrinsic signals. Adenosine, purine nucleoside catabolite ATP, one standard signals TME that drives macrophage polarization by activating adenosine receptor (ADOR)....
Background Radical resection is the only curative method for patients with pancreatic adenocarcinoma (PDAC). However, nearly 85% of PDAC suffer from local or distant recurrence within 5 years after resection. The progression recurrent lesions accelerates mortality rate in patients. influence clinicopathological factors on post-progression-free survival (PPFS), defined as period tumor to timing lesions, has rarely been discussed. present study aimed explore independent prognostic PPFS and...
Abstract Background Accurate assessment of the nature enlarged retropharyngeal lymph nodes (RLN) nasopharyngeal carcinoma (NPC) patients after radiotherapy is essential for planning treatment. This study aimed to develop a non-invasive and effective model predicting recurrence RLN (RRLN) in NPC. Methods The data post-radiotherapy NPC (N = 76) with abnormal enlargement who underwent endonasopharyngeal ultrasound-guided fine-needle aspirations (EPUS-FNA) were examined. They randomly divided...
Accurate assessment of the nature enlarged retropharyngeal lymph nodes (RLN) nasopharyngeal carcinoma (NPC) patients after radiotherapy is related to selecting appropriate treatments and avoiding unnecessary therapy. This study aimed develop a non-invasive effective model for predicting recurrence RLN (RRLN) in NPC. The data post-radiotherapy NPC (N = 76) with abnormal enlargement who underwent endonasopharyngeal ultrasound-guided fine-needle aspirations (EPUS-FNA) were examined. They...
Objective To investigate the efficacy of combined hyperfractionated radiation therapy (HFX RT) plus accelerated HFX RT and concomitant chemotherapy (CHT) in stage ⅢA or ⅢB non-small-cell lung cancer (NSCLC) compared with alone. Methods From August 1998 to December 2001, 56 patients NSCLC were randomized into following groups: alone group (group Ⅰ, n=28), 1.2 Gy twice daily a total dose 45.6 Gy, followed by 1.6 daily, planned was 68.0 tumour; RT/CHT Ⅱ, same CHT consisting 20 mg/m2 cisplatin...